Results for tag: "Pertzye"

Pertzye is a brand of pancreatic enzyme replacement therapy (PERT) used to treat exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis, chronic pancreatitis, and other conditions. PERT is a type of endocrine and metabolic disorder drug that helps to break down fats, proteins, and carbohydrates in the digestive system. PERT is typically taken orally, and is available in both capsule and powder form. PERT is also used to treat malabsorption syndromes, such as celiac disease, and to improve nutrient absorption in patients with short bowel syndrome. The Pertzye market is a subset of the larger endocrine and metabolic disorder drug market. It is a rapidly growing market, driven by the increasing prevalence of EPI and other conditions that require PERT. The market is highly competitive, with several major players offering PERT products. Companies in the Pertzye market include AbbVie, Pfizer, Janssen, and Novartis. Show Less Read more